Scarica l'app Stockscreener
9.62
3.70%
-0.37
Pre-mercato:
10.40
0.78
+8.11%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RXST Giù?
Forum
Previsione
Precedente Chiudi:
$9.99
Aprire:
$10
Volume 24 ore:
748.07K
Relative Volume:
0.99
Capitalizzazione di mercato:
$395.54M
Reddito:
$128.29M
Utile/perdita netta:
$-30.69M
Rapporto P/E:
-11.73
EPS:
-0.82
Flusso di cassa netto:
$-27.17M
1 W Prestazione:
-7.68%
1M Prestazione:
-23.83%
6M Prestazione:
-22.61%
1 anno Prestazione:
-72.98%
Intervallo 1D:
$9.58
$10.00
Intervallo di 1 settimana:
$9.58
$10.85
Portata 52W:
$6.32
$35.60
Rxsight Inc Stock (RXST) Company Profile
Nome
Rxsight Inc
Settore
Industria
Telefono
949-521-7822
Indirizzo
100 COLUMBIA STREET, ALISO VIEJO
Confronta RXST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
9.62 | 410.76M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
127.04 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.65 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.75 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.77 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.83 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-10 | Downgrade | Jefferies | Buy → Hold |
| 2025-07-09 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-07-09 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-07-09 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-05-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Iniziato | Piper Sandler | Neutral |
| 2025-04-09 | Downgrade | UBS | Buy → Neutral |
| 2025-04-04 | Downgrade | JP Morgan | Overweight → Underweight |
| 2025-04-03 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-12-20 | Downgrade | Stifel | Buy → Hold |
| 2024-12-11 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Iniziato | UBS | Buy |
| 2024-10-29 | Iniziato | Jefferies | Buy |
| 2024-08-20 | Reiterato | Needham | Buy |
| 2024-08-06 | Reiterato | Needham | Buy |
| 2024-05-07 | Reiterato | BTIG Research | Buy |
| 2023-12-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | Iniziato | Stifel | Buy |
| 2023-12-04 | Iniziato | Morgan Stanley | Overweight |
| 2023-04-13 | Iniziato | Oppenheimer | Outperform |
| 2022-12-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | Iniziato | Needham | Buy |
Mostra tutto
Rxsight Inc Borsa (RXST) Ultime notizie
Will RxSight Inc. stock outperform international peers2026 world cup usa national team group stage playmakers possession football tactical prediction tactical review - ulpravda.ru
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Investors to Inquire about Securities Investigation - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. ... - Bluefield Daily Telegraph
Looking At The Narrative For RxSight (RXST) After A Better Than Feared Quarter - Yahoo Finance
RxSight CFO Shelley Thunen to Step Down - Orange County Business Journal
Income Plays: Will RxSight Inc stock outperform value stocksEarnings Growth Summary & Low Risk High Win Rate Picks - moha.gov.vn
RxSight director sells $108,618 in common stock - MSN
Trading the Move, Not the Narrative: (RXST) Edition - Stock Traders Daily
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference - The Manila Times
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc.RXST - PR Newswire
RxSight, Inc. (NASDAQ:RXST) Receives Average Recommendation of "Reduce" from Brokerages - MarketBeat
RxSight, Inc. (RXST) Misses Q4 Earnings Estimates - MSN
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Shareholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Shareholders to Reach Out - ACCESS Newswire
Institutional Owners May Take Dramatic Actions as RxSight, Inc.'s (NASDAQ:RXST) Recent 13% Drop Adds to One-year Losses - 富途牛牛
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), MDxHealth (MDXH) and RxSight (RXST) - The Globe and Mail
RxSight enters transition agreement with outgoing CFO Shelley Thunen By Investing.com - Investing.com South Africa
RxSight, Inc. Announces Transition of Chief Financial Officer Shelley Thunen - VisionMonday.com
RxSight enters transition agreement with outgoing CFO Shelley Thunen - Investing.com
RxSight Announces CFO Transition and Leadership Continuity Plan - TipRanks
RxSight Announces CFO Transition - TradingView — Track All Markets
RxSight (RXST) sets CFO transition and consulting deal, keeps 2025 outlook - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
RxSight CFO exit raises concerns over pace of recovery, BTIG says - Investing.com Canada
RxSight (NASDAQ:RXST) Shares Gap DownShould You Sell? - MarketBeat
RxSight Shares Fall After Company Says CFO Shelley Thunen to Step Down - marketscreener.com
RxSight down on CFO transition (RXST:NASDAQ) - Seeking Alpha
RxSight Chief Financial Officer Shelley Thunen to Step Down - marketscreener.com
Rxsight, Inc. announces chief financial officer transition - marketscreener.com
RxSight announces planned transition of longtime CFO Thunen - TipRanks
RXST FinancialsIncome Statement - Quiver Quantitative
RxSight, Inc. Announces CFO Transition - TradingView — Track All Markets
RxSight, Inc. Announces Chief Financial Officer Transition - GlobeNewswire
Tunwal E Rebound Backed by Sentiment ShiftPrice Support Zones & Free Real-Time Trading Alerts Every Day - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Thrivent Financial for Lutherans Lowers Holdings in RxSight, Inc. $RXST - MarketBeat
RxSight Announces Executive Leadership Reorganization and New Appointments - TipRanks
RxSight, Inc. Announces Executive Appointments - TradingView — Track All Markets
RxSight, Inc. Appoints Eric Weinberg as Chief Business Development Officer and Scott Gaines as Chief Customer Officer, Effective December 18, 2025 - marketscreener.com
RxSight Earnings Notes - Trefis
Why RxSight Inc. stock is a value investor pickDip Buying & Safe Entry Trade Signal Reports - DonanımHaber
Will RxSight Inc. stock outperform value stocks2025 Sector Review & Expert Verified Stock Movement Alerts - DonanımHaber
Is RxSight Inc. stock trading at a premium valuationJuly 2025 Breakouts & Risk Managed Investment Strategies - Улправда
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
RxSight announces executive leadership reorganization and new appointments - MSN
Midday Stock Roundup: RXSight Falls After CFO Announcement - Orange County Business Journal
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Investors to Connect - ACCESS Newswire
Squarepoint Ops LLC Raises Stock Holdings in RxSight, Inc. $RXST - MarketBeat
How the Narrative Surrounding RxSight Is Shifting After a Strong but Debated Quarter - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Wells Fargo Reaffirms Their Hold Rating on RxSight (RXST) - The Globe and Mail
Rxsight Inc Azioni (RXST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.64%
0.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):